文献速递乳房整形与再造美容整形

肿瘤整形乳房缩小术与良性巨乳症乳房缩小术的结局比较

Comparing Outcomes after Oncoplastic Breast Reduction and Breast Reduction for Benign Macromastia.
PubMed 文献 · Plast Reconstr Surg · 2022-01-01

该回顾性研究比较了同一术者9年间实施的肿瘤整形乳房缩小术(62例)与良性巨乳症乳房缩小术(149例)的并发症差异,并比较了肿瘤整形组内患侧与对称侧并发症。结果显示肿瘤整形组乳头感觉丧失率更高,其余并发症无显著差异;肿瘤整形组内患侧并发症率高于对称侧。

要点

  • 肿瘤整形乳房缩小术与标准乳房缩小术的安全性相似,但乳头感觉丧失率更高。
  • 肿瘤整形组内,患侧乳房并发症率高于对称侧乳房。
  • 两组在总切除重量上存在差异,良性组更大。

核心结论

  • 肿瘤整形乳房缩小术患者乳头感觉丧失增加,但所有其他结局在两组间无显著差异;作者认为肿瘤整形乳房缩小术的安全性可与标准乳房缩小术相似。

研究设计与样本

  • 回顾性病历审查,纳入同一术者9年间行肿瘤整形或良性乳房缩小术的女性患者211例,其中肿瘤整形组62例(29.4%),良性巨乳症组149例(70.6%)。

主要发现

  • 良性组总切除重量大于肿瘤整形组(p=0.00)。
  • 肿瘤整形组乳头感觉丧失率高于良性组(p=0.005),其他任何并发症无差异。
  • 在肿瘤整形队列内,患侧乳房并发症率高于对称侧乳房(p=0.039),但各单项并发症率无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oncoplastic breast reconstruction improves cosmetic outcomes when compared to standard breast conservation therapy alone. The authors studied whether tailoring a breast reduction to a cancer resection affects complication rates by comparing (1) outcomes between oncoplastic and benign macromastia patients and (2) complication rates between the cancer side and the symmetrizing side of an oncoplastic reduction. METHODS: A retrospective chart review was performed on female patients who underwent either oncoplastic or benign breast reduction over 9 years by a single surgeon. Patient demographics, intraoperative data, and postoperative outcomes were gathered from the electronic medical record. Chi-square and t tests were performed when appropriate to determine significance. RESULTS: Of the 211 patients included in the study, 62 (29.4 percent) underwent oncoplastic breast reduction and 149 (70.6 percent) underwent breast reduction for benign macromastia. Total resection weight was greater in the benign group (p = 0.00). There was a higher rate of loss of nipple sensation in the oncoplastic group (p = 0.005) but no differences in any other complication. There was a higher complication rate in the oncologic breast when compared to the symmetrizing breast within the oncoplastic cohort (p = 0.039), but no differences in the rates of individual complications. CONCLUSIONS: Although the loss of nipple sensation was increased in patients undergoing oncoplastic breast reduction, all other outcomes were not significantly different between the two groups. The authors' findings indicate that oncoplastic breast reduction can be performed with a safety profile similar to that of a standard breast reduction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Marano AA, Grover K, Peysakhovich A, et al. Comparing Outcomes after Oncoplastic Breast Reduction and Breast Reduction for Benign Macromastia. Plast Reconstr Surg. 2022. PMID: 35006098. doi:10.1097/PRS.0000000000008822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。